MétaCan
Menu
← Back to cohort

MP24-16 PREVALENCE, PREDICTORS OF EXPOSURE AND ATHEROEMBOLIC COMPLICATIONS ASSOCIATED WITH NEOADJUVANT CHEMOTHERAPY IN BLADDER CARCINOMA

2020· article· en· W3023667587 on OpenAlexaboutno aff
Tarik Benidir, Jaime O. Herrera‐Cáceres, Christopher Wallis, Neil Fleshner

Bibliographic record

VenueThe Journal of Urology · 2020
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCystectomyBladder cancerChemotherapyCohortInternal medicineMultivariate analysisPopulationRetrospective cohort studyCancerSurgeryOncology

Abstract

fetched live from OpenAlex

INTRODUCTION AND OBJECTIVE: Level 1 evidence supports neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) for muscle invasive bladder cancer (MIBC) with hopes of improving overall survival. Literature to date is deficient in describing real world population-based outcomes from NAC with reference towards its prevalence, time-trends, predictors of exposure and associated atheroembolic complications (ATE). We herein present the experience in Ontario (an equal access single payer system) from 2002-2018. Objective: to describe trends in the use of NAC in Ontario over a 16 year period and describe the ATE’s in bladder cancer patients treated with either NAC, adjuvant chemotherapy (AC) or RC alone. METHODS: Population-based retrospective study using procedural, hospital and billing related data via the Institute of Clinical Evaluative Sciences. Events/interventions were accrued for 2 years. Patients receiving chemotherapy for bladder metastases or trimodal therapy were excluded. Uni and multivariate analysis were used for outcome comparisons among cohorts. RESULTS: A total of 3281 patients met the inclusion criteria. Only 974/3281 (29.7%) received NAC and among those, 50% did not progress to RC. Time trend analysis showed a significant increase in the use of NAC intent and completion (from 2007 onwards, p<0.05)(Figure 1). The NAC intention-to-treat patients were younger (p<0.001) but had similar comorbidities (mean Charlson Index score (CI) of 0.57 vs 0.71, p=0.1) as compared to the RC+/-AC cohort. Patients receiving NAC whom did not progress to RC (n=490), were older (p<0.001) and more comorbid (mean CI of 0.74 vs. 0.38, p<0.0001) than those completing RC. All groups demonstrated a similar rate of events (8.2% to 12.5% p>0.05) and interventions (2.5%-4.6% p>0.05). Among all chemotherapy exposed patients, age (>75) but not CI was associated with a higher risk for ATE’s (HR 1.98, p<0.001). CONCLUSIONS: In this population-based study, 29.7% of patients were deemed candidates for NAC with half failing to progress to RC. Time trends show consistent increase with NAC intent and completion (2007 onward). Regardless of sequence of chemotherapy exposure, 8.2-12.5% experienced ATE’s with only age as a predictor of risk.Source of Funding: No source

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.077
Threshold uncertainty score0.153

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.249
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Urology→Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→